全球電子產品市場規模、佔有率和成長分析：按產品、類型、應用和地區 - 產業預測（2024-2031）

2022年，全球電子藥品市場規模為239億美元，從2023年的255.7億美元成長到2031年的439.4億美元，預計在預測期內（2024-2031年）將以複合年成長率成長。 。

由於醫療技術的進步、研發成本的增加、人口老化和慢性病盛行率的上升，電子產品市場預計將大幅成長。由於患者傾向於侵入性較小的治療，與植入式設備相比，預計非侵入性設備的需求將會很大。然而，嚴格的法律規範、頻繁的產品召回、漫長的核准流程和高成本等挑戰可能會阻礙市場潛力。全球心血管疾病的增加預計將進一步推動市場擴張，特別是在電子藥物用於治療這些疾病方面。各國政府已開始提供資金以加強研發工作，這表明支持性環境可以在未來四年內顯著擴大市場機會。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 次要/一級資訊來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2023）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 技術進步
• 監管環境

電子藥品市場規模：依產品分類，複合年成長率（2024-2031）

• 市場概況
• 心臟心律調節器和植入式心臟整流去顫器
• 人工電子耳
• 神經調節
  • 脊髓刺激設備
  • 深層腦部刺激器
  • 迷走神經刺激設備
  • 薦骨神經刺激器
  • 胃電刺激設備
  • 經皮神經刺激設備
  • 經顱磁刺激器
  • 呼吸電刺激設備
  • 三叉神經刺激設備
  • 反應性神經刺激設備
• 視網膜植入

電子藥品市場規模：依類型，複合年成長率（2024-2031）

• 市場概況
• 植入式電醫療裝置
• 非侵入性電療設備

電子藥品市場規模：依應用分類，複合年成長率（2024-2031）

• 市場概況
• 心臟心律調節器和植入式心臟整流去顫器(ICD)
  • 心律不整
  • 心臟衰竭
  • 其他心臟心律調節器和 ICD 應用
• 脊髓刺激設備
  • 慢性疼痛
  • 背部手術失敗綜合症
  • 缺血
  • 帕金森氏症
  • 發抖
  • 憂鬱症
  • 其他星展銀行應用程式
  • 尿失禁
  • 大便失禁
  • 癲癇
  • 其他 VNS 應用
  • 胃輕癱
  • 肥胖
  • 抗治療性憂鬱症
  • 其他 TENS 應用
  • 偏頭痛
  • 脊髓損傷
  • 注意力不足/過動症

電子保健品市場規模，複合年成長率（2024-2031）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2023）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2021-2023）

主要企業簡介

• Medtronic
• Boston scientific corporation
• Abbott
• Livanova plc
• Cochlear ltd.
• Microport scientific corporation
• Sonova
• Nevro corp.
• Axonics, Inc.
• Neuronetics
• Electrocore, Inc.
• Neuropace, Inc.
• Biotronik
• Medico SRL
• Zhejiang nurotron biotechnology co., ltd.
• Med-EL
• Aleva neurotherapeutics
• Neurosigma, inc.
• Biowave corporation
• Soterix medical Inc

結論和建議

Global Electroceuticals Market size was valued at USD 23.9 billion in 2022 and is poised to grow from USD 25.57 billion in 2023 to USD 43.94 billion by 2031, growing at a CAGR of 7.0% during the forecast period (2024-2031).

The electroceuticals market is poised for significant growth, driven by advancements in medical technology, increasing research and development spending, an aging population, and a rising prevalence of chronic diseases. Non-invasive devices are expected to see higher demand compared to implantable options as patients lean towards less invasive treatments. However, challenges such as stringent regulatory frameworks, frequent product recalls, lengthy approval processes, and high costs may hinder market potential. The global rise in cardiovascular diseases will further fuel market expansion, particularly in the utilization of electroceuticals for these conditions. Governments are initiating funding to bolster R&D efforts, indicating a supportive environment that could significantly enhance market opportunities over the next four years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Electroceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Electroceuticals Market Segmental Analysis

Global Electroceuticals Market is segmented by product, type, application and region. Based on product, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators, cochlear implants, neuromodulators and retinal implants. Based on type, the market is segmented into implantable electroceutical devices and noninvasive electroceutical devices. Based on application, the market is segmented into cardiac pacemakers & implantable cardioverter defibrillators (ICD) and spinal cord stimulators. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Electroceuticals Market

A key driver of growth in the global electroceuticals market is the increasing incidence of cardiovascular diseases, which are among the leading causes of mortality worldwide. The World Health Organization reports that these diseases result in over 17.3 million deaths annually, with projections suggesting this number may rise to 23.6 million by 2030. Cardiovascular diseases affect approximately 31% of the global population, disproportionately impacting low and middle-income countries, where they account for 80% of fatalities. In the United States alone, over 800,000 deaths attributed to cardiovascular conditions were reported, illustrating a significant opportunity for expansion within the electroceuticals sector. Additionally, innovations and new product launches by key market players further propel market growth in the foreseeable future.

Restraints in the Global Electroceuticals Market

One significant constraint on the Global Electroceuticals market is the limited awareness of electroceutical devices among populations in low and middle-income countries (LMIC). Although high-income nations have successfully adopted a variety of implantable devices, including those for cardiac rhythm management, access remains scarce in LMIC. Research from the American Heart Association indicates that many Latin Americans in the United States are unfamiliar with automated external defibrillators (AEDs) and their operation. This lack of public knowledge is detrimental because it hampers potential survival rates following cardiac arrests, as individuals might not receive essential defibrillation treatment in critical situations.

Market Trends of the Global Electroceuticals Market

The global electroceuticals market is experiencing significant growth, fueled by increased investment from numerous key players such as Medtronic, Boston Scientific, and Abbott Laboratories. This escalating trend is driven by the expanding product portfolios and innovative therapies that address various diseases, alongside strategic initiatives like mergers, acquisitions, and technological advancements. Recent FDA approvals, including Medtronic's Intellis Platform and Boston Scientific's Vercise Genus system, illustrate the rapid development in this sector. As the industry embraces advanced technologies and collaborative efforts, the market is poised for robust expansion, catering to the increasing demand for minimally invasive therapeutic options worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape

Global Electroceuticals Market Size by Product & CAGR (2024-2031)

• Market Overview
• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Cochlear Implants
• Neuromodulators
  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Vagus Nerve Stimulators
  • Sacral Nerve Stimulators
  • Gastric Electrical Stimulators
  • Transcutaneous Electrical Nerve Stimulators
  • Transcranial Magnetic Stimulators
  • Respiratory Electrical Stimulators
  • Trigeminal Nerve Stimulators
  • Responsive Neurostimulators
• Retinal Implants

Global Electroceuticals Market Size by Type & CAGR (2024-2031)

• Market Overview
• Implantable Electroceutical Devices
• Noninvasive Electroceutical Devices

Global Electroceuticals Market Size by Application & CAGR (2024-2031)

• Market Overview
• Cardiac Pacemakers & Implantable Cardioverter Defibrillators (ICD)
  • Arrhythmia
  • Heart Failure
  • Other Cardiac Pacemaker & Icd Applications
• Spinal Cord Stimulators
  • Chronic Pain
  • Failed Back Surgery Syndrome
  • Ischemia
  • Parkinson'S Disease
  • Tremors
  • Depression
  • Other Dbs Applications
  • Urine Incontinence
  • Fecal Incontinence
  • Epilepsy
  • Other Vns Applications
  • Gastroparesis
  • Obesity
  • Treatment-Resistant Depression
  • Other Tens Applications
  • Migraine
  • Spinal Cord Injury
  • Attention-Deficit/Hyperactivity Disorder

Global Electroceuticals Market Size & CAGR (2024-2031)

• North America (Product, Type, Application)
  • USA
  • Canada
• Europe (Product, Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston scientific corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Livanova plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cochlear ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microport scientific corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nevro corp.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axonics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Electrocore, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuropace, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medico S.R.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang nurotron biotechnology co., ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Med-EL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aleva neurotherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neurosigma, inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biowave corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soterix medical Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations